Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The graduating cohort comprised seven batches across five specialized programs
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Targeting deadly drug-resistant acinetobacter infections
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
